Diagnóstico molecular das infecções por Chlamydia trachomatis e ...

Bos MP, Kuroki M, Krop-Watorek A, Hogan D, Belland RJ 1998. CD66 receptor
specificity exhibited by neisserial Opa variants is controlled by protein determinants
in CD66 N-domains. Proc Natl Acad Sci 95: 9584–9589.
Brunham RC, Rey-Ladino J 2005. Immunology of Chlamydia infections: implications
for a Chlamydia trachomatis vaccine. Nature Reviews 5: 149-161.
Buchholz KR, Stephens RS 2006. Activation of the host cell proinflammatory
interleukin-8 response by Chlamydia trachomatis. Cell Microbiol 8: 1768-1779.
CDC 2002. Screening tests to detect Chlamydia trachomatis and Neisseria
gonorrhoeae infections. MMWR 51.
CDC 2006. Sexually transmitted diseases treatment guidelines. Disponível em:
http://www.cdc.gov/std/treatment/2006/rr5511.pdf. Data de Acesso: 12/07/2010.
CDC 2007. Fact Sheet Gonorrhea. Content Update. Disponível em:
http://www.cdc.gov/std/gonorrhea/gonorrhea-fact-sheet.pdf. Data de acesso:
17/06/2010.
CDC 2009a. Sexually Transmitted Disease Surveillance. Chlamydia Prevalence
Monitoring Project. Disponível em:
http://www.cdc.gov/std/Chlamydia2007/CTSurvSupp2007Short.pdf. Data de acesso:
08/06/2010.
CDC 2009b. Sexually Transmitted Disease Surveillance. Gonococcal Isolate
Surveillance Project (GISP). Disponível em:
http://www.cdc.gov/std/gisp2007/GISPSurvSupp2007Short.pdf. Data de acesso:
08/06/2010.
Chan EL, Brandt K, Olienus K, Antonishyn N, Horsman GB 2000. Performance
characteristics of the Becton Dickinson ProbeTec System for direct detection of
Chlamydia trachomatis and Neisseria gonorrhoeae in male and female urine
66